Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1148 | 979 | 1185 | 1258 | 1503 | 2265 |
Fund Return | 14.82% | -2.12% | 18.53% | 7.95% | 8.49% | 8.52% |
Place in category | 88 | 508 | 82 | 94 | 126 | 28 |
% in Category | 4 | 22 | 4 | 6 | 7 | 2 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GS India Equity Portfolio E Acc | 5.1B | 25.81 | 11.64 | 11.38 | ||
GS Global CORE Equity Portfolio E C | 4.92B | 29.33 | 10.52 | 10.69 | ||
GS Global CORE Equity Portfolio I E | 4.92B | 30.86 | 11.95 | 12.16 | ||
Goldman Sachs Global CORE Equity Pe | 4.92B | 28.65 | 9.80 | 10.63 | ||
GS EM Equity Portfolio E Acc | 3.05B | 13.45 | -5.34 | 4.44 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
European Growth Fund A Acc EUR | 156.67M | 17.05 | 6.54 | 5.62 | ||
European Growth Fund E Acc EUR | 20.34M | 16.23 | 5.74 | 4.83 | ||
European Growth Fund Y Acc EUR | 248.03M | 17.90 | 7.45 | 6.50 | ||
European Growth Fund Y DIST EUR | 63.75M | 17.95 | 7.47 | 6.51 | ||
European Growth Fund A DIST Eue | 6.48B | 17.06 | 6.55 | 5.62 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 4.34 | 589.2 | -20.72% | |
SAP | DE0007164600 | 3.61 | 236.750 | -0.13% | |
Roche Holding Participation | CH0012032048 | 3.21 | 247.40 | +0.28% | |
Novartis | CH0012005267 | 3.03 | 86.72 | -0.37% | |
Nestle | CH0038863350 | 2.40 | 73.98 | -0.30% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Neutral | Buy |
Technical Indicators | Sell | Sell | Strong Buy |
Summary | Strong Sell | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review